Technical analysis of Nuwellis, Inc. (NUWE): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc.
Price Performance
| 1 month | -31.51% |
| 3 months | -82.55% |
| Year-to-date | -98.66% |
| 1 year | -99.41% |
| 3 years | -100.00% |
| 5 years | -100.00% |
52-Week Range
| 52-week High | $172.90 |
| 52-week Low | $0.71 |
| Avg Volume (90d) | 2.4M |
Technical Indicators
| SMA 50 | $1.68 |
| SMA 200 | $38.59 |
| 30-day Volatility (annualised) | 80.5% |
| Price vs SMA 50 | -51.5% |
| Price vs SMA 200 | -97.9% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $100.10 | |
| 2025-11 | $85.40 | -14.7% |
| 2025-12 | $60.90 | -28.7% |
| 2026-01 | $131.95 | +116.7% |
| 2026-02 | $52.85 | -59.9% |
| 2026-03 | $36.75 | -30.5% |
| 2026-04 | $39.55 | +7.6% |
| 2026-05 | $27.08 | -31.5% |
| 2026-06 | $3.05 | -88.7% |
| 2026-07 | $1.74 | -43.0% |
| 2026-08 | $0.79 | -54.5% |
| 2026-09 | $0.81 | +2.8% |
Price
| Price | $0.81 |
| Market Cap | $0M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | -0.07 |
| EV / EBITDA | 0.50 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | -0.10 |
| Current Ratio | 1.97 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -74.53 |